SCHEMBL23292267

SCHEMBL23292267

CCCCOC(=O)N1CC[C@H](Nc2ccc(C#N)cn2)C1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2D6 P10635 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ HSD11B1 P28845 2/20 0.55
▸ HSD11B2 P80365 1/20 0.55
▸ CCNK O75909 3/20 0.52
▸ CDK12 Q9NYV4 3/20 0.52
▸ CCR6 P51684 7/20 0.49
▸ USP30 Q70CQ3 1/20 0.46
▸ NOS2 P35228 2/20 0.45
▸ JAK3 P52333 2/20 0.45
▸ JAK2 O60674 1/20 0.45
▸ DPP4 P27487 1/20 0.44
▸ HRH2 P25021 1/20 0.44
▸ HRH1 P35367 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ NOS3 P29474 1/20 0.44
▸ NOS1 P29475 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1036089 0.88 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL1036091 0.88 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL23292286 0.88 CCNK (0.50) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL23292322 0.86 NOS2 (0.52) CCNKCDK12CCR6NOS2NOS3
SCHEMBL23292432 0.84 CCNK (0.51) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL1036416 0.82 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL1036415 0.82 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL23292365 0.82 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL2636995 0.81 HRH2 (0.41) CYP3A4CYP2D6CYP2C9HSD11B1HSD11B2
SCHEMBL30088942 0.80 HRH1 (0.48) HRH2HRH1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3813819-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES Kinnate Biopharma Inc. (US) 2021-05-05 — — EP disclosed
Send feedback